Log in to save to my catalogue

Antithrombotic Medication and Major Complications After Mechanical Aortic Valve Replacement

Antithrombotic Medication and Major Complications After Mechanical Aortic Valve Replacement

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2847345030

Antithrombotic Medication and Major Complications After Mechanical Aortic Valve Replacement

About this item

Full title

Antithrombotic Medication and Major Complications After Mechanical Aortic Valve Replacement

Publisher

United States: Elsevier Inc

Journal title

The American journal of cardiology, 2023-10, Vol.204, p.185-194

Language

English

Formats

Publication information

Publisher

United States: Elsevier Inc

More information

Scope and Contents

Contents

Patients with mechanical aortic valve replacement (AVR) require lifelong vitamin K antagonist (VKA) therapy for stroke and systemic embolism prevention. However, VKA treatment predisposes patients to various types of bleeding. In the present study, we sought to assess the success of antithrombotic therapy and the occurrence and timing of strokes an...

Alternative Titles

Full title

Antithrombotic Medication and Major Complications After Mechanical Aortic Valve Replacement

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2847345030

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2847345030

Other Identifiers

ISSN

0002-9149

E-ISSN

1879-1913

DOI

10.1016/j.amjcard.2023.07.097

How to access this item